SEC Form 4 · accession 0001840706-26-000248
SOPHiA GENETICS SA · SOPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kevin Puylaert
Officer — Chief Sales Officer
Period of report
Jul 6, 2026
Accepted (ET)
Jul 7, 2026 · 4:03 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001840706
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1 | Jul 6, 2026 | S | 138 | $5.0251 | D | 148,026 | D | |
| Ordinary SharesF1 | Jul 6, 2026 | S | 47 | $5.0251 | D | 147,979 | D | |
| Ordinary SharesF2 | Jul 6, 2026 | S | 31 | $5.0862 | D | 147,948 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares sold by the Reporting Person in the open market to satisfy tax obligations in connection with the vesting of restricted stock units on July 2, 2026. The sales were effected as a "sell to cover" transaction and do not represent discretionary trades.
- F2Represents shares sold by the Reporting Person in the open market to satisfy tax obligations in connection with the vesting of restricted stock units on July 3, 2026. The sales were effected as a "sell to cover" transaction and do not represent discretionary trades.